Drug susceptibility of Candida isolated from the surfaces of mobile phones and hands.
Introduction: The mycological literature currently devotes much attention to the issue of reduced fungal susceptibility to commonly used antifungal drugs.
Purpose: To assess drug susceptibility of Candida strains isolated from samples collected from the surfaces of mobile phones and the hands of their owners. A total of 175 mobile telephones belonging to students and lecturers of the Medical University of Bialystok and University Hospital personnel as well as 175 hands of these phone owners were included in the mycological evaluation.
Results: The rate of Candida contamination of personal mobile phones was more than 70.0%. C. glabrata strains were primarily isolated from the collected material (89.1% - hands; 74.9% - mobile phones). C. albicans strains showed susceptibility to most antimycotics, with the highest susceptibility to 5-fluorocytosine, and the lowest to fluconazole. C. glabrata showed the lowest susceptibility to fluconazole and miconazole, and the highest to ketoconazole. C. krusei were relatively very sensitive to antibiotics, except for fluconazole. None of the isolated strains showed resistance to more than three types of drugs.
Conclusion: This study demonstrated that mobile phones are potentially vehicles for pathogenic Candida strains in a university and hospital settings.
Keywords Candida, isolated, mobile phones
Mobile phones are widely used by healthcare workers and could be colonized by potential bacteria and fungi pathogens. Mobile phones are potential vectors for transferring nosocomial pathogens between health care workers', patients, and the community [1-2]. The mobile phones are used routinely all day long but they are cleaned rarely by medical staff.
Numerous previous studies assessed contamination of mobile phones among the health care workers [2-5].
Ulger et al.  determined the contamination rate of the healthcare workers' mobile phones and hands in operating room and intensive care units. 200 healthcare workers were screened; samples from the hands of 200 participants and 200 mobile phones were cultured. They found that 94.5% of phones demonstrated evidence of bacterial contamination with different types of bacteria. In a similar study, Foong et al.  investigated the potential role of mobile phones as a reservoir for bacterial colonization and the risk factors for bacterial colonisation in a hospital setting. They screened 226 staff members at a regional Australian hospital (146 doctors and 80 medical students). They found a high level of bacterial contamination 74% on the mobile phones of staff members in a tertiary hospital.
Very few studies [6,7] have been carried out to understand the role played by mobile phones in spreading fungi especially nosocomial pathogens.
Candida spp. are currently the fourth most common cause of bloodstream infections in US hospitals, and the third most common cause of bloodstream infections in the intensive care unit .
The mycological literature devotes much attention to the issue of fungal resistance and reduced susceptibility to commonly used antifungal drugs [8-13], and it emphasizes that the process is still in progress, especially for azole chemotherapeutics (ketoconazole, tioconazole, miconazole, fluconazole, itraconazole).
For example, C. glabrata and C. krusei show primary resistance to fluconazole . Resistance to amphotericin B most frequently occurs in C. parapsilosis, C. lusitaniae, C. quillermondii, C. tropicalis, and C. krusei. The growing resistance of Candida strains to azole antifungals also should be mentioned [14-15].
To our knowledge, there are no reports on drug susceptibility of fungal strains isolated from mobile phone surfaces in the scientific literature. Since mobile phones are regarded as potential vectors of infection, it seemed advisable to investigate the selected aspects of pathogenicity of fungi isolated from mobile phone surfaces, especially in light of the fact that the world literature lacks such reports.
The aim of the study was to asses the drug susceptibility of Candida strains isolated from samples collected from the surfaces of mobile phones and the hands of their owners.
MATERIALS AND METHODS
The Bioethics Committee of the Medical University of Bialystok approved the study, approval no. RI-002/489/2010.
A total 175 staff - 75 students and 25 lecturers of the Medical University of Bialystok and 100 healthcare staff of the University Hospital were screened; cultures were subsequently obtained from the dominant hand of participants and their mobile phones at the same time. The sampling of the dominant hand (including ventral surface) and mobile phone (surface of the contact with the ventral hand) of the participants were performed by Count-TacTM.
We used Count-TactTM applicator using Count-Tact plates (bioMerieux) containing a medium complying with the requirements of the Draft European Standard CEN/TC 243/WG2. CandiSelect (Bio-Rad) was used to identify yeastlike fungi.
Drug susceptibility was assessed using FUNGITEST[R] (Sanofi Diagnostics Pasteur) for the analysis of fungal growth in the presence of six drugs, such as 5-fluorocytosine, amphotericin B, miconazole, ketoconazole, itraconazole and fluconazole used at two concentrations, in modified RPMI 1640 medium, in the presence of a redox indicator. The mycological procedures were in accordance with the manufacturer's instructions.
The results were interpreted according to the manufacturer's instructions, always by the same person and always with reference to the color of two wells containing the same drug: a blue color in both wells indicated an in vitro susceptible strain; a pink color at lower concentrations and a blue color at higher concentrations indicated an in vitro strain with low susceptibility; and a pink color in both wells indicated an in vitro resistant strain.
Numerical characteristics of the evaluated parameters and percentage values, the [Chi.sup.2] test was used for statistical analysis. P values < 0.05 were considered significant. Statistica 10.0 PL software was used for these analyses.
In this study, the rate of Candida contamination of personal mobile phones was more than 70.0%. We isolated the following strains from the material collected from the surfaces of the hands of mobile phone owners: C. glabrata (89.1%); C. albicans (83.4%); C. krusei (69.7%); and C. tropicalis (5.1%). We isolated the following strains from the material collected from mobile phone surfaces: C. glabrata (74.9%); C. albicans (65.1%); C. krusei (54.3%), and C. tropicalis (6.3%). Significant correlations in Candida contamination between hands and mobile phones were found as follow: C. albicans R=0.450, p<0.001; C. glabrata R=0.260 P=0.0039; C. krusei R=0.290, p=0.0089; C. tropicalis R=0.152, p=0.0431.
C. albicans strains showed susceptibility to most types of antimycotics, with the highest susceptibility to 5-fluorocytosine, and the lowest to fluconazole (Table 1). In the case of isolates from the hand, none of the strains showed resistance to amphotericin B; in the case of isolates from mobile phones, none of the strains showed resistance to amphotericin B or miconazole. We observed more cases of resistant strains among the isolates from hand surfaces compared with mobile phones.
C. glabrata showed the lowest susceptibility to fluconazole and miconazole, and the highest to ketoconazole (Table 2). Strains isolated from mobile phone surfaces showed slightly higher susceptibility compared with those from the hands of the respondents. Assessment of the significance of differences in the susceptibility level of C. glabrata isolated from hand and mobile phone surfaces showed no statistically significant differences in susceptibility to the analyzed drugs.
C. krusei showed a relatively high susceptibility to antibiotics, except for fluconazole (Table 3). The results we obtained for strains collected from hands and mobile phones were very similar. The highest resistance was observed for fluconazole. Assessment of the significance of differences in the susceptibility level of C. krusei isolated from hand and mobile phone surfaces. There were no statistically significant differences in susceptibility to the analyzed drugs.
Susceptibility assessment of C. tropicalis strains may indicate high randomness due to the small number of subjects colonized by these fungi. The results we obtained for strains collected from hands and mobile phones were similar (Table 4).
We also assessed the simultaneous resistance of the evaluated fungal strains to one or more of the tested antifungal drugs (Table 5). The drugs to which certain strains were resistant were summed for each individual who had fungal strains isolated from mobile phone or hand surfaces. None of the isolated strains showed resistance to more than three types of drugs. Since we were able to perform the analysis only based on the results for individuals who had fungal strains of a certain type isolated from both their hand and mobile phone surfaces, we excluded the two least common strains from analysis.
The rate of routine cleaning of medical personnel's mobile phones was 67.4%, which means 32.6% of the participants never cleaned their mobile phones.
In this study, the rate of Candida contamination of personal mobile phones among medical students and physicians was more than 70.0%. We demonstrated C. glabrata, C. albicans, and C. krusei were the most common strains isolated from the material collected from mobile phone surfaces. Candida strains showed susceptibility to most types of antimycotics. We also demonstrated significant correlations in Candida strains contamination between hands and mobile phones were found.
The possibility transmissions of nosocomial pathogens by electronic devices such as personal digital assistants, handheld computers, and mobile phones were previously reported and some of them were epidemiologically important drug-resistant pathogens [16-18].
Healthcare workers can also carry Candida on their hands [19-20]. Seventy-five percent of the nurses and 81% of the nonnurses were found to harbor yeasts on their hands; 58% of nurses and 38% of nonnurses were carrying Candida spp.  Yildirim et al. isolated Candida spp., from hands of 30.7% nurses, 25.8% resident doctors, and 28.6% laboratory workers.
There have been a few outbreaks of candidemia linked to healthcare workers' hands, so is important for preventing the spread of infections [21-22].
C. albicans is the most prevalent opportunistic fungal pathogens of human. Candida can live as a harmless commensal of humans, and is carried in almost half of the population  Colonization of Candida in distinct sites including skin, oral gastrointestinal tract and vaginal mucosal surfaces are extremely common in healthy individuals. The Candida infection is more prevalent in patients with impaired host defenses, during chemotherapies, organ transplants, cancer therapy, use of prosthetic devices, patients using broad-spectrum antibiotics and in AIDS patients
Over the last decade, there have been important changes in the epidemiology of Candida infections and antifungal agents used to treat these infections. In recent years, Candida spp. have emerged as important causes of invasive infections among patients in intensive care units, in immunocompromised patients and use indwelling medical devices .
Non-C.albicans species such as C. glabrata, C. tropicalis and C. parapsilosis are now frequently identified as human pathogens. Furthermore, infections (candidiasis) due to C. tropicalis have increased dramatically on a global scale thus proclaiming this organism to be an emerging pathogenic yeast .
In the hospitals, usually attention is paid to changing clothes, removing jewellery, covering hair, and hand hygiene to reduce the transfer of microorganisms from the external clinical environment into the hospitals rooms. However, less attention is paid to using mobile phones in the hospitals. So it is important to know the Candida load on mobile phones used by students and medical staff within the university and hospitals. Mobile phones should be regarded as the potential source of nosocomial infections with Candida.
In general, Candida species are not assumed to be primary causative pathogens in ventilator-associated pneumonia patients .
In a post-mortem study in patients with evidence of pneumonia at autopsy, none of the subjects with a tracheal aspirate or bronchoalveolar lavage culture positive for Candida species had histopathological evidence of invasive Candida growth .
However, there is evidence that colonisation of the lower respiratory tract by Candida species promotes the development of pneumonia by creating biofilms that are capable of holding other micro-organisms .
It is suggested that multifocal Candida spp. findings increase the risk of a systemic Candida spp. infection, and thereby increase risk for morbidity and mortality. Azoulay et al.  found in a multicenter cohort of 800 patients that pulmonary Candida spp. colonization was significantly associated with an increased risk of nosocomial pneumonia and prolonged length of stay at the intensive care unit.
Fungal pneumonia is an infectious process in the lungs caused by one or more endemic or opportunistic fungi. Fungal infection occurs following the inhalation of spores, after the inhalation of conidia, or by the reactivation of a latent infection. Hematogenous dissemination frequently occurs, especially in an immunocompromised host. Opportunistic fungal organisms (e.g. Candida species, Aspergillus species, Mucor species) tend to cause pneumonia in patients with congenital or acquired defects in the host immune defenses .
In the present study, C. albicans strains isolated from hand surfaces did not show resistance to amphotericin B, and the strains from mobile phone surfaces were not resistant to amphotericin B nor miconazole.
The literature [31-32] emphasized that C. krusei and C. glabrata strains have a natural resistance to fluconazole and decreased susceptibility to 5-fluorocytosine. In our study, C. glabrata showed the highest resistance to fluconazole from hands and mobile phones.
There has been an increase in the occurrence of drug-resistant strains of bacteria since the introduction of antibiotics. An increase in drug resistance has also been observed among Candida spp.
In our study, C. krusei isolated from mobile phone and hands showed each 92.6% resistance to fluconazole; 70.4% of isolates from mobile phones and 66.4% from hand surfaces were susceptible to 5-fluorocytosine. Isolates from hand and mobile phone surfaces occasionally showed resistance to more than three types of drugs. This is in agreement with previous reports [33-35].
Krajewska-Kulak et al.  assessed the susceptibility of the yeast-like fungi strains using the Fungitest method The yeast-like fungi strains isolated from 406 patients with symptoms of candidiasis (oral cavity, vagina, urethra, skin, nails, and stomach) were evaluated. Differences between the susceptibility of strains isolated from different sites of the body to tested drugs were found. High resistance of tested strains to several antimycotics were identified. Fungitest is an easy and effective method in assessing the susceptibility of yeast-like fungi strains to antimycotics.
In the present study, we also used Fungitest method to assess drug susceptibility. We found that C. albicans strains were more resistant to antifungal agents isolated from hands compared to isolates from mobile phones. In contrast, the susceptibility of C. glabrata strains from mobile phone surfaces was higher compared with strains collected from the hands. Although the results obtained for C. krusei and C. tropicalis isolates from hand and mobile phone surfaces were very similar.
In our study, susceptibility to fluconazole was shown by 64.1% of C. glabrata strains isolated from hand surfaces and 60.6% of strains isolated from mobile phones. In the case of C. krusei, none of the strains from hand or mobile phone surfaces was susceptible to fluconazole. Perhaps, strains isolated from mobile phone surfaces, as opposed to organic materials, may have different drug susceptibility.
In the present study, we identified fungi using selective, differential medium, CHROMagar Candida Medium, for isolation and identification of C. albicans, C. tropicalis, and C. krusei, which according to many authors [37-38] can easily be used for direct identification of C. albicans, C. krusei and C. tropicalis. Reports indicating high sensitivity and specificity of the differentiation of Candida strains grown on CHROMagar[R] Candida can be found in the literature [37-38].
Some authors reported a low rate of cleaning mobile phones by the medical staff. The rate of routine cleaning of healthcare worker's mobile phones was 10.5%, which means 89.5% of the participants never cleaned their mobile phones (1). In another study,  only 37% of healthcare workers cleaned their phones. And, 75% of the participants did not view a ban on phones as a practical solution was they found to be an infection risk.
In our study, the rate of routine cleaning of medical personnel's mobile phones was rather high, (67.4%), which means 32.6% of the participants never cleaned their mobile phones.
The education of medical personnel mobile phone as source of Candida contamination, hand hygiene, environmental disinfection, and disinfection
methods of mobile phones are of great importance. Developing active preventive strategies like routine decontamination of mobile phones with alcohol containing disinfectant materials might reduce cross-infection.
1. Candida glabrata, Candida albicans, and Candida krusei were the most common strains isolated from the material collected from mobile phone surfaces.
2. In the case of C. albicans and C. glabrata, isolates from hand surfaces were more resistant; whereas in the case of C. krusei and C. tropicalis, resistance was comparable for both strains isolated from hand and phone surfaces.
3. Isolates from hand and mobile phone surfaces sporadically showed resistance to more than three types of drugs, and these most often included C. glabrata isolated from hand surfaces.
Conflicts of interest
The authors declare that they have no conflicts of interest.
[1.] Ulger F, Esen S, Dilek A, Yanik K, Gunaydin M, Leblebicioglu H. Are we aware how contaminated our mobile phones with nosocomial pathogens? Ann Clin Microbiol Antimicrob. 2009 Mar;8(7):1-4.
[2.] Chao Foong Y, Green M, Zargari A, Siddique R, Tan V, Brain T, Ogden K. Mobile Phones as a Potential Vehicle of Infection in a Hospital Setting. J Occup Environ Hyg. 2015;12(10): D232-5.
[3.] Brady RR, Wasson A, Stirling I, McAllister C, Damani NN. Is your phone bugged? The incidence of bacteria known to cause nosocomial infection on healthcare workers' mobile phones. J Hosp Infect. 2006 Jan;62 (1):123-5.
[4.] Brady RR, Fraser SF, Dunlop MG, Paterson-Brown S, Gibb AP. Bacterial contamination of mobile communication devices in the operative environment. J Hosp Infec. 2007 Aug;66 (4):397-8.
[5.] Bhoonderowa A, Gookool S, Biranjia-Hurdoyal SD. The importance of mobile phones in the possible transmission of bacterial infections in the community. J Community Health. 2014 Oct;39(5):965-7.
[6.] Tambe NN, Pai CA. Study of Microbial Flora and MRSA Harboured by Mobile Phones of Health Care Personnel. Int J Rec Trends Sci Technol. 2012 Jan;4(1):14-8.
[7.] Ozkan VK, Sulun Y. Microfungal contaminants on mobile phones of health services vocational school students in Marmaris, Turkey. Mycopathologia 2014 Feb;177(1-2):59-64.
[8.] Lewis RE. Overview of the changing epidemiology of candidemia. Curr Med Res Opin. 2009 Jul;25(7):1732-40.
[9.] Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W, Borgers M, Ramaekers FC, Odds FC, Bossche HV. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 1999 Oct;145(Pt 10):2701-13.
[10.] Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006 Mar;50(3):917-21.
[11.] Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods. J Clin Microbiol. 2007 Jan; 45(1):70-5.
[12.] Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis. 2002 Feb;2(2):73-85.
[13.] Iatta R, Caggiano G, Cuna T, Montagna MT. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia. J Chemother. 2011;23(2):92-6.
[14.] Perlin DS, Shor E, ZhaoY. Update on Antifungal Drug Resistance. Curr Clin Microbiol Rep. 2015 Apr;2(2):84-95.
[15.] Xie JL, Polvi EJ, Shekhar-Guturja T. Cowen LE. Elucidating drug resistance in human fungal pathogens. Future Microbiol. 2014;9 (4):523-42.
[16.] Singh V, Aggarwal V, Bansal S, Garg SP, Chowdhary N. Telephone mouthpiece as a possible source of hospital infection. J Assoc Physicians India Apr 1998;46(4):372-3.
[17.] Brady RR, Wasson A, Stirling I, McAllister C, Damani NN. Is your phone bugged? The incidence of bacteria known to cause nosocomial infection on healthcare workers' mobile phones. J Hosp Infect. 2006 Jan;62 (1):123-5.
[18.] Isaacs D, Daley A, Dalton D. Swabbing computers in search of nosocomial bacteria. Ped Infect Dis J.1998 Jun;17(6):533.
[19.] Strausbaugh LJ, Sewell DL, Ward TT, Pfaller MA, Heitzman T, Tjoelker R. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol. 1994 Sep;32(9):2299-300.
[20.] Yildirim M, Sahin I, Kucukbayrak A, Ozdemir D, Tevfik Yavuz M, Oksuz S, Cakir S. Hand carriage of Candida species and risk factors in hospital personnel. Mycoses 2007 May;50(3): 189-92.
[21.] Clark TA, Slavinski SA, Morgan J, Lott T, Arthington-Skaggs BA, Brandt ME, Webb RM, Currier M, Flowers RH, Fridkin SK, Hajjeh RA. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol. 2004 Oct;42(10):4468-72.
[22.] Pappas PG. Invasive candidiasis. Infect Dis Clin North Am.2006 Sep;20(3):485-506.
[23.] Kourkoumpetis T, Manolakaki D, Velmahos G, Chang Y, Alam HB, De Moya MM, Sailhamer EA, Mylonakis E. Candida infection and colonization among non-trauma emergency surgery patients. Virulence Sep-Oct 2010 Sept-Oct;1(2): 359-66.
[24.] Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012 Mar;36(2):288-305.
[25.] Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol Aug 2010;59(8):873-80.
[26.] Ricard JD, Roux D. Candida pneumonia in the ICU: myth or reality? Intensive Care Med Sep 2009;35(9):1500-2.
[27.] Playford EG, Lipman J, Kabir M, McBryde ES, Nimmo GR, Lau A, Sorrell TC. Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med Dec 2009;35(12):2141-5.
[28.] Leon C, Ruiz-Santana S, Saavedra P, Galvan B, Blanco A, Castro C, Balasini C, Utande-Vazquez A, Gonzalez de Molina FJ, Blasco-Navalproto MA, Lopez MJ, Charles PE, Martin E, Hernandez-Viera MA; Cava Study Group. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med May 2009;37(5):1624-33.
[29.] Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, Adrie C, Garrouste-Orgeas M, Cohen Y, Mourvillier B, Schlemmer B; Outcomerea Study Group. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest Jan 2006;129(1):110-7.
[30.] Smith JA, Kauffman CA. Pulmonary fungal infections. Respirology Aug 2012;17(6):913-26.
[31.] Pfaller MA, Diekema DJ, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev Apr 2006;19(2):435-47.
[32.] Chen TC, Chen YH, Chen YC, Lu PL. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents. Kaohsiung J Med Sci Jun 2012;28(6):306-15.
[33.] Yang YL, Chen HT, Lin CC, Chu WL, Lo HJ, TSARY Hospitals. Species distribution and drug susceptibilities of Candida isolates in TSARY 2010. Diagn Microbiol Infect. Dis Jun 2013;76(2):182-6.
[34.] Hager JL, Mir MR, Hsu S. Candida krusei fungemia in an immunocompromised patient. Dermatol Online J Apr 2010;16(4):5.
[35.] Azevedo AC, Bizerra FC, da Matta DA, de Almeida LP, Rosas R, Colombo AL. In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay. Mycopathologia Jun 2011;171(6):411-6.
[36.] Krajewska-Kulak E, Lukaszuk C, Green J, Wronska I, Chadzopulu A, Kotrotsiou E, Kaba E, Theodosopoulou E. Resistance of the yeastlike fungi strains isolated from different ontogeneses of patients. Dermatol Nurs Jun 2004;16(3):259-65.
[37.] Pfaller MA, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol Jan 1996;34(1):58-61.
[38.] Jabra-Rizk MA, Brenner TM, Romagnoli M, Baqui AA, Merz WG, Falkler WA Jr, Meiller TF. Evaluation of a reformulated CHROMagar Candida. J Clin Microbiol May 2001;39(5): 2015-6.
[39.] Mark D, Leonard C, Breen H, Graydon R, O'Gorman C, Kirk S. Mobile phones in clinical practice: reducing the risk of bacterial contamination. Int J Clin Pract Sep 2014; 68(9):1060-4.
Kordecka A. (*1A-F), Krajewska-Kulak E. (2A,C,D,E,F), Lukaszuk C. (2B,C,D,E,F), Kraszynski M. (3B,C), Kraszynska B (2B,C)
(1.) Department of Anesthesiology and Intensive Therapy, Medical University of Bialystok, Poland
(2.) Department of Integrated Medical Care, Medical University of Bialystok, Poland
(3.) Medical University Hospital, Medical University of Bialystok, Poland
(A) - Conception and study design; (B) - Collection of data; (C) - Data analysis; (D) - Writing the paper; (E) - Review article; (F) - Approval of the final version of the article; (G) - Other (please specify)
(*) Corresponding author: Kordecka Anna Department of Anesthesiology and Intensive Therapy Medical University of Bialystok, Poland email: email@example.com
Received: 02.04. 2016
Table 1. Assessment of drug susceptibility of Candida albicans strains Drug Susceptibility to antibiotic high susceptibility low susceptibility Hand* 5-fluorocytosine 97 66.4% 45 30.8% amphotericin B 76 52.1% 70 47.9% miconazole 68 46.6% 64 43.8% ketoconazole 83 56.8% 39 26.7% itraconazole 87 59.6% 35 24.0% fluconazole 75 51.4% 27 18.5% Phone 5-fluorocytosine 91 79.8% 22 19.3% amphotericin B 89 78.1% 25 21.9% miconazole 84 73.7% 30 26.3% ketoconazole 73 64.0% 39 34.2% itraconazole 83 72.8% 28 24.6% fluconazole 58 50.9% 37 32.5% Drug resistant strain Hand* 5-fluorocytosine 4 2.7% amphotericin B 0 0.0% miconazole 14 9.6% ketoconazole 24 16.4% itraconazole 24 16.4% fluconazole 44 30.1% Phone 5-fluorocytosine 1 0.9% amphotericin B 0 0.0% miconazole 0 0.0% ketoconazole 2 1.8% itraconazole 3 2.6% fluconazole 19 16.7% hand vs phone [Chi.sup.2] test ad 5-fluorocytosine - p=0.009 ad amphotericin B p=0.0003 ad miconazole--p= 0.0000 ad ketoconazole--p=0.0229 ad itraconazole--p=0.0003 ad fluconazole--p=0.0052 Table 2. Assessment of drug susceptibility of Candida glabrata strains Drug Susceptibility to antibiotic high susceptibility low susceptibility Hand 5-fluorocytosine 100 64.1% 54 34.6% amphotericin B 102 65.4% 51 32.7% miconazole 76 48.7% 77 49.4% ketoconazole 118 75.6% 38 24.4% itraconazole 101 64.7% 52 33.3% fluconazole 72 46.2% 72 46.2% Phone 5-fluorocytosine 80 60.6% 49 37.1% amphotericin B 82 62.1% 48 36.4% miconazole 74 56.1% 56 42.4% ketoconazole 99 75.0% 33 25.0% itraconazole 91 68.9% 39 29.5% fluconazole 53 40.2% 69 52.3% Drug resistant strain Hand 5-fluorocytosine 2 1.3% amphotericin B 3 1.9% miconazole 3 1.9% ketoconazole 0 0.0% itraconazole 3 1.9% fluconazole 12 7.7% Phone 5-fluorocytosine 3 2.3% amphotericin B 2 1.5% miconazole 2 1.5% ketoconazole 0 0.0% itraconazole 2 1.5% fluconazole 10 7.6% hand vs phone [Chi.sup.2] test ad 5-fluorocytosine--p=0.2496 ad amphotericin B--p=0.8979 ad miconazole--p=0.2389 ad ketoconazole--p=0.7317 ad itraconazole--p=0.8203 ad fluconazole--p=0.1307 Table 3. Assessment of drug susceptibility of Candida krusei strains Drug Susceptibility to antibiotic high susceptibility low susceptibility Hand 5-fluorocytosine 81 66.4% 36 29.5% amphotericin B 93 76.2% 28 23.0% miconazole 80 65.6% 42 34.4% ketoconazole 76 62.3% 46 37.7% itraconazole 98 80.3% 24 19.7% fluconazole 0 0.0% 9 7.4% Phone 5-fluorocytosine 57 70.4% 21 25.9% amphotericin B 66 81.5% 15 18.5% miconazole 53 65.4% 28 34.6% ketoconazole 56 69.1% 25 30.9% itraconazole 69 85.2% 12 14.8% fluconazole 0 0.0% 6 7.4% Drug resistant strain Hand 5-fluorocytosine 5 4.1% amphotericin B 1 0.8% miconazole 0 0.0% ketoconazole 0 0.0% itraconazole 0 0.0% fluconazole 113 92.6% Phone 5-fluorocytosine 3 3.7% amphotericin B 0 0.0% miconazole 0 0.0% ketoconazole 0 0.0% itraconazole 0 0.0% fluconazole 75 926% hand vs phone [Chi.sup.2] test ad 5-fluorocytosine - 0.361 ad amphotericin B - 0.361 ad miconazole - 0.875 ad ketoconazole - 0.186 ad itraconazole - 0.637 ad fluconazole - 1.000 Table 4. Assessment of drug susceptibility of Candida tropicalis strains Drug Susceptibility to antibiotic high susceptibility low susceptibility Hand 5-fluorocytosine 7 77.8% 2 22.2% amphotericin B 4 44.4% 5 55.6% miconazole 5 55.6% 4 44.4% ketoconazole 8 88.9% 1 11.1% itraconazole 9 100.0% 0 0.0% fluconazole 0 0.0% 6 66.7% Phone 5-fluorocytosine 4 44.4% 5 55.6% amphotericin B 3 33.3% 6 66.7% miconazole 9 100.0% 0 0.0% ketoconazole 8 88.9% 1 11.1% itraconazole 8 88.9% 1 11.1% Drug resistant strain Hand 5-fluorocytosine 0 0.0% amphotericin B 0 0.0% miconazole 0 0.0% ketoconazole 0 0.0% itraconazole 0 0.0% fluconazole 3 33.3% Phone 5-fluorocytosine 0 0.0% amphotericin B 0 0.0% miconazole 0 0.0% ketoconazole 0 0.0% itraconazole 0 0.0% Table 5. Simultaneous resistance of the evaluated fungal strains to one or more of the tested antifungal drugs Number Fungal strain of drugs a Candida Candida given albicans glabrata fungal hand phone hand phone strain was N % N % N % N % resistant to 0 52 36 91 80 137 88 114 86 1 79 54 21 18 16 10 17 13 2 14 10 2 2 2 1 1 1 3 1 1 0 0 1 1 0 0 Number Fungal strain of drugs a Candida Candida given krusei tropicalis fungal hand phone hand phone strain was N % N % N % N % resistant to 0 9 7 6 7 6 67 5 56 1 107 88 72 89 3 33 4 44 2 6 5 3 4 0 0 0 0 3 0 0 0 0 0 0 0 0
|Printer friendly Cite/link Email Feedback|
|Author:||Kordecka, A.; Krajewska-Kulak, E.; Lukaszuk, C.; Kraszynski, M.; Kraszynska, B.|
|Publication:||Progress in Health Sciences|
|Date:||Jun 1, 2017|
|Previous Article:||Snacking in children according to age.|
|Next Article:||Effects of religious beliefs on the assessment of nurses' work in the perception of patients, nursing students and nurses.|